CWM, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
CWM, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$63
-11.3%
3,891
+127.9%
0.00%
Q2 2023$71
-42.3%
1,707
-16.8%
0.00%
-100.0%
Q1 2023$123
-19.1%
2,051
-1.3%
0.00%0.0%
Q4 2022$152
-99.9%
2,079
+12.9%
0.00%0.0%
Q3 2022$140,000
+14.8%
1,841
+5.3%
0.00%0.0%
Q2 2022$122,000
-9.0%
1,749
+8.2%
0.00%0.0%
Q1 2022$134,000
+44.1%
1,616
+30.9%
0.00%0.0%
Q4 2021$93,000
-69.6%
1,235
-10.6%
0.00%
-50.0%
Q2 2021$306,0000.0%1,3810.0%0.00%0.0%
Q1 2021$306,0000.0%1,3810.0%0.00%0.0%
Q4 2020$306,0000.0%1,3810.0%0.00%0.0%
Q3 2020$306,0000.0%1,3810.0%0.00%0.0%
Q2 2020$306,0000.0%1,3810.0%0.00%0.0%
Q1 2020$306,0000.0%1,3810.0%0.00%0.0%
Q4 2019$306,0000.0%1,3810.0%0.00%0.0%
Q3 2019$306,0000.0%1,3810.0%0.00%0.0%
Q2 2019$306,0000.0%1,3810.0%0.00%0.0%
Q1 2019$306,000
+75.9%
1,381
-73.4%
0.00%
-50.0%
Q4 2018$174,000
-36.0%
5,2000.0%0.00%
-42.9%
Q3 2018$272,000
+66.9%
5,2000.0%0.01%
+40.0%
Q2 2018$163,0005,2000.01%
Other shareholders
NOVOCURE LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$77,833,00015.51%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Darsana Capital Partners LP 700,000$155,274,0004.42%
MORGAN JESS S & CO INC 23,775$5,274,0003.47%
Soleus Capital Management, L.P. 98,975$21,955,0003.38%
Montanaro Asset Management Ltd 116,650$25,875,0003.26%
Taylor Frigon Capital Management LLC 31,035$6,884,0002.15%
Rhenman & Partners Asset Management AB 120,000$26,618,0001.81%
COURAGE CAPITAL MANAGEMENT LLC 10,000$2,218,0001.33%
Derbend Asset Management 5,789$1,284,0001.20%
View complete list of NOVOCURE LTD shareholders